MORTIMACROLATE TABLETS is an immunosuppressant that can be used to prevent rejection in patients receiving allogeneic heart, liver, or kidney transplants.
MORTIMACROSOLATE can be used concomitantly with tacrolimus, cyclosporine and corticosteroids to prevent rejection in patients receiving allogeneic heart, liver or kidney transplants, and is essentially an immunosuppressant drug that acts by inhibiting the enzyme hypoxanthine mononucleotide dehydrogenase, and has strict indications for its use.
The drug is contraindicated in patients who are allergic to any component of the drug, pregnant women, lactating women and women of childbearing age who are not contraceptives. Common adverse drug reactions after taking the drug include infection, malaise, fever, headache, anemia, hematuria, hypertension, ecchymosis, hypercholesterolemia, hyperglycemia, hyperkalemia, constipation, diarrhea, dyspepsia, and so on.
Pay attention to the prevention and control of infection during the use of the drug, pay attention to sun protection to reduce the risk of skin cancer.
Matemacrolate tablets is a prescription drug, need to be used strictly under the guidance of a physician, it is recommended that patients who need to take matemacrolate tablets for treatment to the relevant departments of the regular hospital in time for consultation, to avoid taking medication on their own.